Heart failure & cardiomyopathies
Clinical Implication of Sarcopenia in Patients with Acute Decompensated Heart Failure: Design and Rationale
Study context
- Population
- Adults >18 years hospitalised for acute decompensated HF (acute decompensated heart failure (ADHF))planned ≥500
- Planned comparison
- Sarcopenia vs no sarcopenia
- Primary endpoint
- All-cause mortality
- Follow-up
- 6 months
Methodological detailsdesign and rationale, multicentre, observational, Follow-up at 6 months, 1 year, 2 years or until endpoint, Other outcomes: CV mortality, all-cause hospitalisation, HF hospitalisation, survival time from enrolment to event
- Design and rationale
- Multicentre
- Observational
- Follow-up at 6 months, 1 year, 2 years or until endpoint
- Other outcomes: CV mortality, all-cause hospitalisation, HF hospitalisation, survival time from enrolment to event
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Clinical Implication of Sarcopenia in Patients with Acute Decompensated Heart Failure: Design and Rationale. ESC Heart Fail. Published 3 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →